UNSPSC 51161713: Amiphenazole

This classification denotes a cns stimulant with the molecular formula C9H9N3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7ZJ8PWY0XD, chemically known as 2,4-thiazolediamine, 5-phenyl- but generally known as amiphenazole, which bears US NIH Compound Identifier 10275. Amiphenazole most often comes in base and hydrochloride forms. European Medicines Agency schedules Amiphenazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05453MIG.

UNSPSC 51161713 Amiphenazole, a Commodity code, nominally designates a specific pharmaceutical active ingredient, but recent state and local solicitations tagged under this code are actually procuring finished emergency-response pharmaceutical products and pharmacy services rather than amiphenazole itself. Seminole County, Florida released an IFB in June 2026 to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually—opioid-overdose reversal agents and controlled-substance destruction systems for community health support. Hall County, Georgia simultaneously issued an RFQ/P in May 2026 to engage a single on-site pharmacy services provider to stock and dispense a formulary of 25 medications across multiple therapeutic categories to approximately 3,005 eligible individuals enrolled in the county's group health insurance plans. The actual procurement activity under this code spans emergency pharmaceutical supplies and integrated pharmacy management services, not the narrower chemical compound the code nominally names. Issuing bodies include county government health departments and county employee health benefit programs, suggesting the code captures health-services procurement across multiple county functions rather than pharmaceutical manufacturing or chemical ingredient supply.

Recent activity concentrates in the Southeast—Seminole County and Hall County, Georgia—with mixed issuing-body types and timelines that do not align cleanly. Seminole County's IFB posted June 30, 2026, with a July 26, 2023, response deadline (an apparent data inconsistency in the source), sought quarterly deliveries of naloxone and drug deactivation systems with fixed-fee unit pricing and a two-year initial term plus one-year renewal option. Hall County's RFQ/P posted May 4, 2026, with responses due June 4, 2026, used an 80/20 technical-to-cost scoring structure, required 80 evaluated questions covering experience, qualifications, HIPAA compliance, and performance metrics, and offered a one-year initial term beginning January 1, 2027, with four optional one-year renewals. Neither solicitation disclosed explicit set-aside designations. Both required E-Verify compliance, drug-free workplace certification, and comprehensive insurance documentation. The code shows limited recent signal; whether it reflects true procurement activity in this space or a classification mismatch between the chemical ingredient and the actual products and services being bought remains unclear from the available record.